neurocalcin δ inhibitors primarily revolves around modulating calcium signaling. At the heart of this process is the selective control of calcium concentrations, which can indirectly influence the activity of neurocalcin δ. Chemicals like BAPTA-AM, Nifedipine, and Verapamil act by disrupting the balance of calcium, either by chelating it or by blocking channels that mediate its flow into cells. When intracellular calcium levels are altered, proteins like neurocalcin δ, which are sensitive to these levels, can be indirectly affected.
Furthermore, compounds like U73122, which inhibit enzymes like phospholipase C, and TMB-8, which interferes with calcium release from intracellular stores, introduce a secondary level of control over calcium-responsive proteins. By targeting key components and regulators of calcium signaling, it's possible to indirectly modulate the function of calcium-binding proteins, including neurocalcin δ.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Modulates IP3 receptor activity, indirectly affecting intracellular calcium concentrations. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits sarcoplasmic/endoplasmic reticulum Ca^2+-ATPase (SERCA), elevating cytoplasmic calcium levels. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
An L-type calcium channel blocker, which modulates calcium influx, indirectly affecting calcium signaling proteins like neurocalcin δ. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Another L-type calcium channel blocker, alters calcium signaling and can influence proteins that are responsive to calcium concentrations. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Acts on ryanodine receptors in the sarcoplasmic reticulum, modulating calcium release. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
An L-type calcium channel blocker, affecting calcium concentrations and subsequently proteins like neurocalcin δ. | ||||||
TMB-8 • HCl | 53464-72-5 | sc-3522 sc-3522A | 10 mg 50 mg | $43.00 $129.00 | 10 | |
Interferes with calcium release from intracellular stores. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that can affect various calcium-mediated processes, potentially impacting neurocalcin δ. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
Blocks calcium channels, thus altering intracellular calcium signaling. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
An inhibitor of receptor-mediated calcium entry, affecting downstream calcium-responsive proteins. | ||||||